1,3-disubstituted pyrrolidines
    7.
    发明授权
    1,3-disubstituted pyrrolidines 失效
    1,3-二取代吡咯烷

    公开(公告)号:US5274097A

    公开(公告)日:1993-12-28

    申请号:US682785

    申请日:1991-04-09

    摘要: Novel 1,3-disubstituted pyrrolidines active on the central nervous system of the formula ##STR1## wherein A--denotes phenyl or hetaryl, which is optionally fused with aromatic, saturated or unsaturated cyclic or heterocyclic hydrocarbons, where this radical can optionally be substituted,X--denotes --O--CH.sub.2 --, --CH.sub.2 --O-- or --O--,n--denotes a number from 1 to 19, andB--denotes cyano or a group of the formula --COOR.sup.1, --CONR.sup.2 R.sup.3, --SO.sub.2 NR.sup.2 R.sup.3, --SO.sub.m R.sup.4, --NR.sup.5 R.sup.6, or --C.tbd.C--CH.sub.2 --NR.sup.5 R.sup.6,and salts thereof.

    摘要翻译: 在式(I)的中枢神经系统上活性的新的1,3-二取代吡咯烷,其中A表示苯基或杂芳基,其任选地与芳族,饱和或不饱和的环状或杂环烃稠合,其中该基团可任选地 被取代,X表示-O-CH 2 - , - CH 2 -O-或-O-,n - 表示1至19的数,B表示氰基或式-COOR 1,-CONR 2 R 3 - SO2NR2R3,-SOmR4,-NR5R6或-C3OND C-CH2-NR5R6,及其盐。

    1,3-disubstituted pyrrolidines
    8.
    发明授权
    1,3-disubstituted pyrrolidines 失效
    1,3-二取代吡咯烷

    公开(公告)号:US5453437A

    公开(公告)日:1995-09-26

    申请号:US118376

    申请日:1993-09-08

    摘要: Novel 1,3-disubstituted pyrrolidines active on the central nervous system of the formula ##STR1## wherein A--denotes phenyl or hetaryl, which is optionally fused with aromatic, saturated or unsaturated cyclic or heterocyclic hydrocarbons, where this radical can optionally be substituted,X--denotes --O--CH.sub.2 --, --CH.sub.2 --O-- or --0--,n--denotes a number from 1 to 19, andB--denotes cyano or a group of the formula --COOR.sup.1, --CONR.sup.2 R.sup.3, --SO.sub.2 NR.sup.2 R.sup.3, --SO.sub.m R.sup.4, --NR.sup.5 R.sup.6, or --C.tbd.C--CH.sub.2 --NR.sup.5 R.sup.6,and salts thereof.

    摘要翻译: 在式(I)的中枢神经系统上活性的新的1,3-二取代吡咯烷,其中A表示苯基或杂芳基,其任选地与芳族,饱和或不饱和的环状或杂环烃稠合,其中该基团可任选地 被取代,X表示-O-CH 2 - , - CH 2 -O-或-O-,n - 表示1至19的数,B表示氰基或式-COOR 1,-CONR 2 R 3 - SO2NR2R3,-SOmR4,-NR5R6或-C3OND C-CH2-NR5R6,及其盐。

    Pyridoindole derivatives, compositions and use
    10.
    发明授权
    Pyridoindole derivatives, compositions and use 失效
    吡啶并吲哚衍生物,组合物和用途

    公开(公告)号:US4564613A

    公开(公告)日:1986-01-14

    申请号:US651001

    申请日:1984-09-14

    摘要: Pyridoindoles of the formula ##STR1## in which R.sub.1 represents hydrogen or C.sub.1 -C.sub.4 -alkyl, which is optionally substituted by the radical ##STR2## R.sub.2 and R.sub.3 represent H or form a bond, or R.sub.1 and R.sub.2 together represent O, --O--CH.sub.2 --CH.sub.2 --O-- or --S--CH.sub.2 --CH.sub.2 --S--,R.sub.4 represents H or the ##STR3## or R.sub.3 and R.sub.4 represent O, orR.sub.1 and R.sub.4 are members of an N-containing six-membered ring andR.sub.8 and R.sub.9 represent H or C.sub.1 -C.sub.4 -alkyl, or optionally form, with the N atom, a heterocyclic 5-membered or 6-membered ring, which can optionally also contain a further hetero-atom from the series comprising N, O or S,R.sub.5 represents H, C.sub.1 -C.sub.4 -alkyl or the group ##STR4## or R.sub.5 and R.sub.3 form a bond, andR.sub.10 and R.sub.11 represent C.sub.1 -C.sub.4 -alkyl or are members of an N-containing 5-membered or 6-membered ring,R.sub.6 represents H or C.sub.1 -C.sub.4 -alkyl andR.sub.7 represents halogen,or acid addition salts thereof, which are active on the central nervous system. Novel intermediates are also shown.

    摘要翻译: 其中R 1表示氢或任选被基团R 2和R 3取代的C 1 -C 4 - 烷基的吡咯并吲哚表示H或形成键,或者R 1和R 2一起表示O,-O- CH2-CH2-O-或-S-CH2-CH2-S-,R4代表H或者“或”,R3和R4代表O,或R1和R4是含N的六元环的成员,R8和 R9代表H或C1-C4-烷基,或任选地与N原子形成杂环的5元或6元环,其可以任选地还含有来自包含N,O或S的系列的另外的杂原子, R5表示H,C1-C4-烷基或基团,或R5和R3形成键,R10和R11表示C1-C4-烷基,或是含有N元5元或6元环的成员, R6表示H或C1-C4-烷基,R7表示在中枢神经系统上有活性的卤素或其酸加成盐。 还显示了新的中间体。